Tarnagulla Ventures
Overview
We are a family-owned and run group. The team has a proven track record of identifying successful investment opportunities. Currently, the firm is managed by William and Natalie McNamee.
Investment Focus
- Early-stage companies in the life sciences sector with breakthrough technologies and commercialization potential.
Portfolio Companies
Reach Tarnagulla Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Tarnagulla Ventures
What sectors does Tarnagulla Ventures invest in?
Tarnagulla Ventures invests in Healthcare, Medtech and Biotechnology, and is based in Australia. Tarnagulla Ventures is listed as a vc in the ConnectSafely investor database.
What stage does Tarnagulla Ventures invest at?
Tarnagulla Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 5M.
Which regions does Tarnagulla Ventures invest in?
Tarnagulla Ventures invests across United States and Australia.
Who are the partners at Tarnagulla Ventures?
Team members listed for Tarnagulla Ventures include Natalie Mc (Founder) and William McNamee (Director).
What companies has Tarnagulla Ventures invested in?
Tarnagulla Ventures's portfolio includes Inversago Pharma, Lubris BioPharma, Nacuity Pharmaceuticals, Jupiter Neurosciences, LB Pharmaceuticals, Azora Therapeutics and Prevatex.
How do I contact Tarnagulla Ventures?
Tarnagulla Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
